R. Fox

Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.

Carl A. Brooks, D. Holt, W. Bao, 2017, ACS medicinal chemistry letters.

Chemoselective amide ligations by decarboxylative condensations of N-alkylhydroxylamines and alpha-ketoacids.

Kyle D. Baucom, J. Bode, R. Fox, 2006, Angewandte Chemie.

Total synthesis of bidensyneosides A2 and C: remarkable protecting group effects in glycosylation

B. W. Gung, R. Fox, 2004 .

Diacetoxypiperidinium analogs of acetylcholine.

N. J. Lewis, R. Fox, M. Mertes, 1973, Journal of medicinal chemistry.

A simple incubation flask for 14CO2 collection.

R. Fox, 1971, Analytical biochemistry.

Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4).

Carl A. Brooks, D. Holt, D. Behm, 2019, ACS medicinal chemistry letters.

Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.

R. A. Reid, D. Holt, R. Gampe, 2018, ACS medicinal chemistry letters.